Escitalopram shortage — NL supply status & alternatives

Escitalopram

ATC N06AB10

🇦🇺 AUST R 333541

In supply · Australia

GhEscitalopram AccordEscitalopram Viatris

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇳🇱 NL

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$2.50DPMQ A$19.84details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names	Gh, Escitalopram Accord, Escitalopram Viatris

ATC level 5	N06AB10

ATC level 4	N06AB

Therapeutic category	Auto-created by CBG-MEB (Netherlands) scraper

Controlled substance	No

Marketing-authorisation holders	Generic Health Pty Ltd, Accord Healthcare Pty Ltd, Cipla Australia Pty Ltd, DHP HEALTHCARE LIMITED +4 more

Registrations on file	24

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$2.50

AEMP

Dispensed (DPMQ)

A$19.84

incl. fees

Pack

escitalopram 10 mg tablet, 28

Source: PBSEffective July 2026 · AUD

Other markets

🇬🇧 GB

£1.04

Drug Tariff

🇺🇸 US

US$0.04

Acquisition

🇪🇸 ES

€34.97

Retail price

🇮🇹 IT

€11.76

Retail price

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

24 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Micro Labs LTDSms Pharmaceuticals LTDHec Pharm CO LTDZydus Lifesciences LTDH Lundbeck AsCipla LTD+18 more

Manufacturing countries: India, China, Denmark · Source: FDA List of Drug Master Files

Verified timeline regulator events

🇳🇱 24 June 2026

medium reported

🇨🇦 17 June 2026

medium reported

🇨🇦 5 June 2026

medium reported

🇨🇦 29 May 2026

medium reported

🇨🇦 6 May 2026

medium reported

🇳🇱 21 Apr 2026

medium reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders24 registrations · 8 MA holders

Product	Strength	Form	Market	MA holder	Status
Str	10 mg	—	🇦🇺 AU	—	Active
Noumed	10mg	—	🇦🇺 AU	—	Active
Noumed	20 mg	—	🇦🇺 AU	—	Active
Gh	20 mg	—	🇦🇺 AU	Generic Health Pty Ltd	Active
Apx	20 mg	—	🇦🇺 AU	—	Active
Btc	10 mg	—	🇦🇺 AU	—	Active
Btc	20 mg	—	🇦🇺 AU	—	Active
Str	20 mg	—	🇦🇺 AU	—	Active
Escicor	20mg	tabfc	🇦🇺 AU	Accord Healthcare Pty Ltd	Active
Blooms	10 mg	—	🇦🇺 AU	Cipla Australia Pty Ltd	Active
Blooms	20 mg	—	🇦🇺 AU	Cipla Australia Pty Ltd	Active
Apo	10 mg	—	🇦🇺 AU	—	Active
Apo	20 mg	—	🇦🇺 AU	—	Active
ESCITALOPRAM 15 MG FILM-COATED TABLETS	15 MG	tablet	🇬🇧 GB	DHP HEALTHCARE LIMITED	Active
Cipla	20 mg	—	🇦🇺 AU	Cipla Australia Pty Ltd	Active

+9 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.